It may be that things play out in a middle ground scenario,
It may be that things play out in a middle ground scenario, between the doom and gloom and the pie in the sky. It’s obvious that we are not going to run out of money, as we can sell shares, even if we may not like the terms we will get given the SP. So the doom and gloom bankruptcy will not come to pass . But I also don’t think the reason they are silent is because there is some huge partnership or buyout offer about to be announced. No one would be happier than me if that were the case, but I’m skeptical of that scenario.
The middle ground scenario would be that cancer and Nash are going to take longer than we had hoped as we have to run more traditional trials gather more patients and collect and organize more data, with BTD potentially not happening. Covid is the real head scratcher, and I’m shocked that they have not enrolled a ton of patients in Brazil by now - I think they probably owe us an update on that relatively soon. And then there is the BLA submission. I am hopeful that still happens in Q1, and if so I suppose we would see revenue from HIV later this year early next year?
in other words, things will play out in a positive fashion, but on a slower time frame. That still means this will be a great investment, but not as near term potentially. HIV May be our closest shot on goal, which I would be fine with as long as we can execute the BLA submission.
3
2
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...
Continue Reading
Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...
Continue Reading
China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...
Continue Reading
Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...
Continue Reading
ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...
Continue Reading
Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...
Continue Reading
Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...
Continue Reading
Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....
Continue Reading
Top 5 Most Recently Viewed Articles
Introducing Data Turing's Groundbreaking Platform Data Turing, a cutting-edge technology company, has officially launched a trailblazing platform that is set to change the way brands manage their reputation. This innovative service automates the development of brand narratives through verifiable data, a significant step forward in a world where misinformation is...
Continue Reading
Pfizer Welcomes New Leadership for the MERA Region Pfizer has recently appointed Elif Aral as the Regional President for the Middle East, Russia, and Africa (MERA). This important decision is aimed at strengthening operations across a variety of therapeutic areas, such as oncology, vaccines, internal medicine, and immunology. Enhancing Access to Healthcare In her new...
Continue Reading
Innovative Framework for Fragrance Safety This new approach enhances the safety of aquatic ecosystems. Aurelia Lapczynski, the Principal Scientist at the Research Institute for Fragrance Materials (RIFM), is at the forefront of an essential evolution in assessing fragrance safety in aquatic environments. A newly released manuscript brings significant advancements to how...
Continue Reading
Bitcoin Experiences Decline as Market Dynamics Shift In the evolving landscape of cryptocurrency, leading assets have shown a divergence from stock performance recently. On a day characterized by mixed reactions to weak job data, Bitcoin's value fluctuated. Recent Price Movements At one point, Bitcoin dropped to an intraday low of $109,347.23 before making a modest...
Continue Reading
Important Shareholder Meeting Announcement The Board of Directors of Guardian Capital Group Limited (TSX: GCG) has made a crucial recommendation for its shareholders regarding an upcoming vote that could shape the future of the company. The directors, some of whom abstained from the voting process due to conflicts of interest, recommend that investors vote FOR the...
Continue Reading
